Elevance Health Inc (NYSE: ELV) has reported earnings for its first fiscal quarter (ending March 31) of $9.59 versus $8.37 for the same period a year ago. For the latest four quarters through March 31, E.P.S. were $26.55 versus $25.49 for the same period a year ago.
Recent Price Action
Elevance Health Inc (NYSE: ELV) stock closed at $525.19 on 4/18/24 after a large increase of 3.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 269% of normal. Relative to the market the stock has been strong over the last nine months and has risen 3.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, ELV is expected to continue to be a major Value Builder.
Elevance Health has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Elevance Health has a neutral Appreciation Score of 46 but a good Power Rating of 76, producing the High Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment